EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients

Jenna R Nickless, Kathryn E Bridger, Surabhi B Vora, Adam W Brothers

Journal of the Pediatric Infectious Diseases Society · 25.09.2019 · 8 (4) · 365-367

DOI: 10.1093/jpids/piy094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 09.10.2018. Verfasst von Jenna R Nickless und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Seattle Children's Hospital, Washington. Hauptthemen laut MEDLINE: Administration, Intravenous. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited data exist on intravenous (IV) posaconazole dosing and the risk for hepatotoxicity it confers to children. In this study, we evaluated dosing and resulting trough levels in 10 pediatric patients on IV posaconazole. A therapeutic level in these patients was achieved 95% of the time. We found a median minimum effective dose of 6.55 mg/kg of body weight. No correlation was found between the duration or posaconazole trough level and an increased alanine transaminase level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, IntravenousAdolescentAlanine TransaminaseAntifungal AgentsChildChild, PreschoolDrug MonitoringHumansInfantInfant, NewbornRetrospective StudiesTriazoles

Stichwörter der Autor:innen

childhepatotoxicityintravenouslevelposaconazole

Substanzen

Antifungal AgentsTriazolesposaconazoleAlanine Transaminase

Autor:innen und Institutionen

  • Department of Pharmacy, Seattle Children's Hospital, Washington.
  • Department of Pediatrics, Division of Infectious Diseases, University of Washington School of Medicine, Seattle Children's Hospital, Washington.

Zitieren

APA

Nickless, J. R., Bridger, K. E., Vora, S. B., & Brothers, A. W. (2019). Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients. Journal of the Pediatric Infectious Diseases Society, 8(4), 365-367. https://doi.org/10.1093/jpids/piy094

Vancouver

Nickless JR, Bridger KE, Vora SB, Brothers AW. Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. 2019;8(4):365-367. doi:10.1093/jpids/piy094

BibTeX
@article{Nickless2019,
  author = {Nickless, Jenna R and Bridger, Kathryn E and Vora, Surabhi B and Brothers, Adam W},
  title = {Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2019},
  volume = {8},
  number = {4},
  pages = {365--367},
  doi = {10.1093/jpids/piy094}
}
Kostenlos starten →